Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Kåre A. Gotschalck"'
Autor:
Mikkel H. Christensen, Simon O. Drue, Mads H. Rasmussen, Amanda Frydendahl, Iben Lyskjær, Christina Demuth, Jesper Nors, Kåre A. Gotschalck, Lene H. Iversen, Claus L. Andersen, Jakob Skou Pedersen
Publikováno v:
Genome Biology, Vol 24, Iss 1, Pp 1-25 (2023)
Abstract Circulating tumor DNA detection using next-generation sequencing (NGS) data of plasma DNA is promising for cancer identification and characterization. However, the tumor signal in the blood is often low and difficult to distinguish from erro
Externí odkaz:
https://doaj.org/article/1c9bd3e38e3a47bd98c9d4a9cd664023
Publikováno v:
The Lancet Regional Health. Europe, Vol 47, Iss , Pp 101093- (2024)
Summary: Background: The incidence of colorectal cancer (CRC) in individuals younger than 50 years of age (early-onset CRC) is increasing. Early-onset CRC often present at advanced stage, suggesting a more aggressive cancer course compared to late-on
Externí odkaz:
https://doaj.org/article/9e18131120ca402295220b45464c01d6
Autor:
Tenna Vesterman Henriksen, Thomas Reinert, Mads Heilskov Rasmussen, Christina Demuth, Uffe Schou Løve, Anders Husted Madsen, Kåre Andersson Gotschalck, Lene Hjerrild Iversen, Claus Lindbjerg Andersen
Publikováno v:
Molecular Oncology, Vol 16, Iss 20, Pp 3654-3665 (2022)
Circulating tumour DNA (ctDNA) detection for postoperative risk stratification in cancer patients has great clinical potential. However, low ctDNA abundances complicates detection. Multitarget (MT) detection strategies have been developed to increase
Externí odkaz:
https://doaj.org/article/e7eb84fa40c94606a7b732033305c0d1
Autor:
Jesper Nors, Trine Block Mattesen, Deirdre Cronin-Fenton, Aurélie Mailhac, Jesper Bertram Bramsen, Kåre Andersson Gotschalck, Rune Erichsen, Claus Lindbjerg Andersen
Publikováno v:
Nors, J, Mattesen, T B, Cronin-Fenton, D, Mailhac, A, Bramsen, J B, Gotschalck, K A, Erichsen, R & Andersen, C L 2023, ' Identifying Recurrences Among Non-Metastatic Colorectal Cancer Patients Using National Health Data Registries : Validation and Optimization of a Registry-Based Algorithm in a Modern Danish Cohort ', Clinical epidemiology, vol. 15, pp. 241-250 . https://doi.org/10.2147/CLEP.S396140
Jesper Nors,1,2,* Trine Block Mattesen,1,* Deirdre Cronin-Fenton,3 Aurélie Mailhac,3 Jesper Bertram Bramsen,1,2 Kåre Andersson Gotschalck,2,4 Rune Erichsen,2,3,5 Claus Lindbjerg Andersen1,2 1Department of Molecular Medicine, Aarhus Univ
Autor:
Simon Ladefoged Rasmussen, Christian Torp-Pedersen, Kåre Andersson Gotschalck, Ole Thorlacius-Ussing
Publikováno v:
Rasmussen, S L, Torp-Pedersen, C, Gotschalck, K A & Thorlacius-Ussing, O 2023, ' The effect of antithrombotic treatment on the fecal immunochemical test for colorectal cancer screening : a nationwide cross-sectional study ', Endoscopy, vol. 55, no. 5, pp. 444-455 . https://doi.org/10.1055/a-1992-5598
Background Screening for colorectal cancer (CRC) using the fecal immunochemical test (FIT) has been widely adopted. The use of antithrombotic treatment is increasing in the Western world. This study aimed to assess the effects of antithrombotic treat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b97ec28d8624b0585453b473a64e65ad
https://vbn.aau.dk/da/publications/32de3de5-5a55-499c-be30-5c3706fd11e1
https://vbn.aau.dk/da/publications/32de3de5-5a55-499c-be30-5c3706fd11e1
Autor:
Mikkel H. Christensen, Simon Drue, Mads H. Rasmussen, Amanda Frydendahl, Iben Lyskjær, Christina Demuth, Jesper Nors, Kåre A. Gotschalck, Lene H. Iversen, Claus L. Andersen, Jakob Skou Pedersen
Publikováno v:
Christensen, M H, Drue, S O, Rasmussen, M H, Frydendahl, A, Lyskjær, I, Demuth, C, Nors, J, Gotschalck, K A, Iversen, L H, Andersen, C L & Pedersen, J S 2023, ' Dreams : deep read-level error model for sequencing data applied to low-frequency variant calling and circulating tumor DNA detection ', Genome Biology, vol. 24, no. 1, pp. 99 . https://doi.org/10.1186/s13059-023-02920-1
Circulating tumor DNA detection using Next-Generation Sequencing (NGS) data of plasma DNA is promising for cancer identification and characterization. However, the tumor signal in the blood is often low and difficult to distinguish from errors. We pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::382ea952f0a4f8514212c417e03cfd05
https://pure.au.dk/portal/da/publications/dreams(e90b6a07-f625-49db-a1a8-254dcd069847).html
https://pure.au.dk/portal/da/publications/dreams(e90b6a07-f625-49db-a1a8-254dcd069847).html
Autor:
Claus Lindbjerg Andersen, Andres Cervantes, Alexey Aleshin, Himanshu Sethi, Kåre Andersson Gotschalck, Lene Hjerrild Iversen, Ole Thorlacius-Ussing, Per Vadgaard Andersen, Uffe S. Løve, Anders Husted Madsen, Susana Roselló, Marisol Huerta, Desamparados Roda, Dina Hafez, Derrick Renner, Shruti Sharma, Juan Antonio Carbonell-Asins, Francisco Gimeno-Valiente, Thomas Reinert, Amanda Frydendahl, Noelia Tarazona, Tenna Vesterman Henriksen
Supplementary Data from Circulating Tumor DNA in Stage III Colorectal Cancer, beyond Minimal Residual Disease Detection, toward Assessment of Adjuvant Therapy Efficacy and Clinical Behavior of Recurrences
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3bd19293bf0290fce3fee17bd9d37088
https://doi.org/10.1158/1078-0432.22482374
https://doi.org/10.1158/1078-0432.22482374
Autor:
Claus Lindbjerg Andersen, Andres Cervantes, Alexey Aleshin, Himanshu Sethi, Kåre Andersson Gotschalck, Lene Hjerrild Iversen, Ole Thorlacius-Ussing, Per Vadgaard Andersen, Uffe S. Løve, Anders Husted Madsen, Susana Roselló, Marisol Huerta, Desamparados Roda, Dina Hafez, Derrick Renner, Shruti Sharma, Juan Antonio Carbonell-Asins, Francisco Gimeno-Valiente, Thomas Reinert, Amanda Frydendahl, Noelia Tarazona, Tenna Vesterman Henriksen
Purpose:Sensitive methods for risk stratification, monitoring therapeutic efficacy, and early relapse detection may have a major impact on treatment decisions and patient management for stage III colorectal cancer patients. Beyond assessing the predi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5dd41995a6c7ce96483ecdfeec63c4e5
https://doi.org/10.1158/1078-0432.c.6530903.v1
https://doi.org/10.1158/1078-0432.c.6530903.v1
Autor:
Jonas Kabel, Tenna Vesterman Henriksen, Christina Demuth, Amanda Frydendahl, Mads Heilskov Rasmussen, Jesper Nors, Nicolai J. Birkbak, Anders Husted Madsen, Uffe S. Løve, Per Vadgaard Andersen, Thomas Kolbro, Alessio Monti, Ole Thorlacius-Ussing, Mikail Gögenur, Jeppe Kildsig, Nis Hallundbæk Schlesinger, Peter Bondeven, Lene Hjerrild Iversen, Kåre Andersson Gotschalck, Claus Lindbjerg Andersen
Publikováno v:
Cancers
Volume 15
Issue 4
Pages: 1136
Kabel, J, Henriksen, T V, Demuth, C, Frydendahl, A, Rasmussen, M H, Nors, J, Birkbak, N J, Madsen, A H, Løve, U S, Andersen, P V, Kolbro, T, Monti, A, Thorlacius-Ussing, O, Gögenur, M, Kildsig, J, Schlesinger, N H, Bondeven, P, Iversen, L H, Gotschalck, K A & Andersen, C L 2023, ' Impact of Whole Genome Doubling on Detection of Circulating Tumor DNA in Colorectal Cancer ', Cancers, vol. 15, no. 4, 1136 . https://doi.org/10.3390/cancers15041136
Volume 15
Issue 4
Pages: 1136
Kabel, J, Henriksen, T V, Demuth, C, Frydendahl, A, Rasmussen, M H, Nors, J, Birkbak, N J, Madsen, A H, Løve, U S, Andersen, P V, Kolbro, T, Monti, A, Thorlacius-Ussing, O, Gögenur, M, Kildsig, J, Schlesinger, N H, Bondeven, P, Iversen, L H, Gotschalck, K A & Andersen, C L 2023, ' Impact of Whole Genome Doubling on Detection of Circulating Tumor DNA in Colorectal Cancer ', Cancers, vol. 15, no. 4, 1136 . https://doi.org/10.3390/cancers15041136
Objective: Circulating tumor DNA (ctDNA) is a candidate biomarker of cancer with practice-changing potential in the detection of both early and residual disease. Disease stage and tumor size affect the probability of ctDNA detection, whereas little i
Autor:
Lene Hjerrild Iversen, Claus L. Andersen, Derrick Renner, Thomas Reinert, Ole Thorlacius-Ussing, Desamparados Roda, Tenna V Henriksen, Alexey Aleshin, Andrés Cervantes, Noelia Tarazona, Per Vadgaard Andersen, Shruti Sharma, Susana Roselló, J.A. Carbonell-Asins, Dina Hafez, Anders Husted Madsen, Uffe S. Løve, Kåre Andersson Gotschalck, Amanda Frydendahl, Marisol Huerta, F. Gimeno-Valiente, Himanshu Sethi
Publikováno v:
Henriksen, T V, Tarazona, N, Frydendahl, A, Reinert, T, Gimeno-Valiente, F, Carbonell-Asins, J A, Sharma, S, Renner, D, Hafez, D, Roda, D, Huerta, M, Roselló, S, Madsen, A H, Løve, U S, Andersen, P V, Thorlacius-Ussing, O, Iversen, L H, Gotschalck, K A, Sethi, H, Aleshin, A, Cervantes, A & Andersen, C L 2022, ' Circulating Tumor DNA in Stage III Colorectal Cancer, beyond Minimal Residual Disease Detection, toward Assessment of Adjuvant Therapy Efficacy and Clinical Behavior of Recurrences ', Clinical Cancer Research, vol. 28, no. 3, pp. 507-517 . https://doi.org/10.1158/1078-0432.CCR-21-2404
Clinical cancer research : an official journal of the American Association for Cancer Research
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
Clinical cancer research : an official journal of the American Association for Cancer Research
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
Purpose: Sensitive methods for risk stratification, monitoring therapeutic efficacy, and early relapse detection may have a major impact on treatment decisions and patient management for stage III colorectal cancer patients. Beyond assessing the pred